Tributes to Dr. William ‘Bill’ Burhans PhD https://ancan.org/professor-bill-r-i-p/ ; Medicare coverage for Foundation Medicine genomic sequencing tests; PARP-I niraparib gets FDA breakthrough status; is there a cure in sight for metastatic PCa?; is it worthwhile to genomically sequence Nx (lymphatic) disease?; starting enzalutamide/Xtandi; testosterone recovery post-ADT

On the topic of ‘curing’ metastatic prostate cancer above, two worthwhile articles appeared in my inbox today …. RB or Not RB – That is the Question from our good friend Dr. Charles Ryan. And “What Works for Breast Cancer Should Work for Prostate Cancer, Right?” by Dr. Evan Yu. Be assured there is ample excellent ongoing research aimed at allowing us to justifiably use the ‘C’ word!